Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Neolithic introgression of IL23R-related protection against chronic inflammatory bowel diseases in modern Europeans

  • Ben Krause-Kyora*
  • , Nicolas Antonio da Silva
  • , Elif Kaplan
  • , Daniel Kolbe
  • , Sabine Schade-Lindig
  • , Joachim Wahl
  • , Carola Berszin
  • , Michael Francken
  • , Irina Görner
  • , Kerstin Schierhold
  • , Joachim Pechtl
  • , Gisela Grupe
  • , Johannes Müller
  • , Inken Wohlers
  • , Hauke Busch
  • , David Ellinghaus
  • , Amke Caliebe
  • , Efe Sezgin
  • , Almut Nebel
  • , Stefan Schreiber*
  • *Korrespondierende/r Autor/-in für diese Arbeit
  • Christian-Albrechts Universität zu Kiel
  • Leibniz Forschungszentrum Borstel
  • Izmir Institute of Technology
  • Medizinische Fakultät

Abstract

Background: The hypomorphic variant rs11209026-A in the IL23R gene provides significant protection against immune-related diseases in Europeans, notably inflammatory bowel diseases (IBD). Today, the A-allele occurs with an average frequency of 5% in Europe. Methods: This study comprised 251 ancient genomes from Europe spanning over 14,000 years. In these samples, the investigation focused on admixture-informed analyses and selection scans of rs11209026-A and its haplotypes. Findings: rs11209026-A was found at high frequencies in Anatolian Farmers (AF, 18%). AF later introduced the allele into the ancient European gene-pool. Subsequent admixture caused its frequency to decrease and formed the current southwest-to-northeast allele frequency cline in Europe. The geographic distribution of rs11209026-A may influence the gradient in IBD incidence rates that are highest in northern and eastern Europe. Interpretation: Given the dramatic changes from hunting and gathering to agriculture during the Neolithic, AF might have been exposed to selective pressures from a pro-inflammatory lifestyle and diet. Therefore, the protective A-allele may have increased survival by reducing intestinal inflammation and microbiome dysbiosis. The adaptively evolved function of the variant likely contributes to the high efficacy and low side-effects of modern IL-23 neutralisation therapies for chronic inflammatory diseases. Funding: German Research Foundation (EXC 2167 390884018 and EXC 2150 390870439).

OriginalspracheEnglisch
Aufsatznummer105591
ZeitschrifteBioMedicine
Jahrgang113
Seiten (von - bis)105591
DOIs
PublikationsstatusVeröffentlicht - 03.2025

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

DFG-Fachsystematik

  • 2.21-05 Immunologie

Fingerprint

Untersuchen Sie die Forschungsthemen von „Neolithic introgression of IL23R-related protection against chronic inflammatory bowel diseases in modern Europeans“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren